Insulet Net Worth 2010-2025 | PODD

Interactive chart of historical net worth (market cap) for Insulet (PODD) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. Insulet net worth as of May 16, 2025 is $22.85B.
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $22.854B $2.072B
Insulet Corporation is a leading developer, manufacturer and marketer of the Omnipod Insulin Management System. The system is equipped with a self-adhesive, small and lightweight disposable tubeless Omnipod device along with the wireless and handheld Personal Diabetes Manager (PDM). The Omnipod System is an innovative, discreet and easy-to-use continuous insulin delivery system for people with insulin-dependent diabetes. The Omnipod System consists of Omnipod Insulin Management System ('Omnipod') and the Omnipod DASH Insulin Management System - Insulet's next generation digital mobile Omnipod platform. Insulet has tied up with pharmaceutical and biotechnological companies using customized form of the Omnipod System to deliver a drug at a certain administered volume and over a specified period of time. Insulet has partnered with pharmaceutical and biotechnology companies to tailor the Omnipod System technology platform for the delivery of subcutaneous drugs across other therapeutic areas.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $234.530B 28.20
Boston Scientific (BSX) United States $156.881B 39.27
Stryker (SYK) United States $150.466B 31.46
EssilorLuxottica (ESLOY) France $133.537B 0.00
Medtronic (MDT) Ireland $110.863B 16.19
Lonza Group Ag (LZAGY) Switzerland $49.634B 0.00
Haleon (HLN) United Kingdom $48.673B 27.69
ResMed (RMD) United States $36.905B 27.72
GE HealthCare Technologies (GEHC) United States $33.485B 15.90
Agilent Technologies (A) United States $32.436B 21.43
Terumo (TRUMY) Japan $27.642B 35.90
Koninklijke Philips (PHG) Netherlands $22.587B 16.24
Zimmer Biomet Holdings (ZBH) United States $19.181B 12.32
Baxter (BAX) United States $16.247B 12.13
Smith & Nephew SNATS (SNN) United Kingdom $12.648B 0.00
Sunny Optical Technology (SNPTF) China $9.032B 0.00
Demant (WILYY) Denmark $8.231B 0.00
Bio-Rad Laboratories (BIO) United States $6.767B 23.55
Lantheus Holdings (LNTH) United States $5.621B 14.18
Prestige Consumer Healthcare (PBH) United States $4.402B 19.67
Perrigo (PRGO) Ireland $3.719B 9.43
Haemonetics (HAE) United States $3.532B 15.39
ICU Medical (ICUI) United States $3.480B 25.66
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Envista Holdings (NVST) United States $3.097B 25.73
QuidelOrtho (QDEL) United States $2.263B 15.56
GN Store Nord (GNNDY) Denmark $2.097B 17.37
LeMaitre Vascular (LMAT) United States $1.915B 42.81
AtriCure (ATRC) United States $1.619B 0.00
Neogen (NEOG) United States $1.435B 18.36
Kestra Medical Technologies (KMTS) United States $1.264B 0.00
AdaptHealth (AHCO) United States $1.217B 12.36
Green Thumb Industries (GTBIF) United States $1.182B 26.59
BioLife Solutions (BLFS) United States $1.121B 0.00
InMode (INMD) Israel $1.020B 9.34
Phibro Animal Health (PAHC) United States $0.973B 12.44
CeriBell (CBLL) United States $0.649B 0.00
Evolus (EOLS) United States $0.625B 0.00
Owens & Minor (OMI) United States $0.570B 4.73
Curaleaf Holdings (CURLF) Canada $0.553B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.535B 0.00
Valneva SE (VALN) France $0.524B 0.00
Tilray Brands (TLRY) Canada $0.498B 0.00
Capricor Therapeutics (CAPR) United States $0.431B 0.00
Surmodics (SRDX) United States $0.409B 0.00
SNDL (SNDL) Canada $0.355B 0.00
Cresco Labs (CRLBF) United States $0.335B 0.00
VAREX IMAGING (VREX) United States $0.325B 11.94
SEMPERIT AG HLD (SEIGY) Austria $0.321B 0.00
Canopy Growth (CGC) Canada $0.305B 0.00
Aurora Cannabis (ACB) Canada $0.288B 51.30
Sanara MedTech (SMTI) United States $0.280B 0.00
Sanuwave Health (SNWV) United States $0.276B 0.00
Viemed Healthcare (VMD) United States $0.267B 22.53
Cerus (CERS) United States $0.254B 0.00
ZimVie (ZIMV) United States $0.251B 11.40
Verano Holdings (VRNOF) United States $0.235B 0.00
Biote (BTMD) United States $0.224B 6.31
High Tide (HITI) Canada $0.191B 0.00
Omeros (OMER) United States $0.188B 0.00
Brainsway (BWAY) Israel $0.187B 49.55
Quanterix (QTRX) United States $0.186B 0.00
Organigram Global (OGI) Canada $0.182B 0.00
OraSure Technologies (OSUR) United States $0.182B 0.00
Utah Medical Products (UTMD) United States $0.179B 14.58
TriSalus Life Sciences (TLSI) United States $0.166B 0.00
FitLife Brands (FTLF) United States $0.128B 0.00
Exagen (XGN) United States $0.128B 0.00
Jin Medical (ZJYL) China $0.125B 0.00
TerrAscend (TSNDF) Canada $0.113B 0.00
Agape ATP (ATPC) $0.103B 0.00
MacroGenics (MGNX) United States $0.100B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.088B 0.00
Fonar (FONR) United States $0.080B 10.32
Veru (VERU) United States $0.076B 0.00
Zynex (ZYXI) United States $0.075B 0.00
InterCure (INCR) Israel $0.069B 0.00
Jushi Holdings (JUSHF) United States $0.063B 0.00
Quipt Home Medical (QIPT) United States $0.061B 0.00
United Health Products (UEEC) United States $0.061B 0.00
Cytosorbents (CTSO) United States $0.056B 0.00
Apyx Medical (APYX) United States $0.054B 0.00
ImmuCell (ICCC) United States $0.048B 0.00
Modular Medical (MODD) United States $0.039B 0.00
United-Guardian (UG) United States $0.039B 13.35
Rockwell Medical (RMTI) United States $0.035B 0.00
Safety Shot (SHOT) United States $0.031B 0.00
Allurion Technologies (ALUR) United States $0.024B 0.00
Nephros (NEPH) United States $0.023B 30.86
INLIF (INLF) $0.018B 0.00
Trinity Biotech (TRIB) Ireland $0.015B 0.00
Flora Growth (FLGC) United States $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.011B 0.00
Meihua Medical Technologies (MHUA) China $0.010B 0.00
Innovative Eyewear (LUCY) United States $0.009B 0.00
Senestech (SNES) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
IM Cannabis (IMCC) Canada $0.004B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00